Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 3.09% is 24% above its 5-year average of 2.49%, near the low end of its 5-year range (1.06%–26.84%).
As of the fiscal period ended Friday, July 31, 2026. 3.44% above its 12-month average of 2.99%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-07-31): 3.09%.
DEBT TO ASSETS RATIO
3.09%
DEBT TO ASSETS RATIO AVG TTM
2.99%
DEBT TO ASSETS RATIO AVG 3Y
2.90%
DEBT TO ASSETS RATIO AVG 5Y
2.49%
DEBT TO ASSETS RATIO AVG 10Y
6.89%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+3.44%
CURRENT VS 3Y AVG
+6.65%
CURRENT VS 5Y AVG
+24.43%
CURRENT VS 10Y AVG
-55.10%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 779 covered companies
CURRENT VS SECTOR MEDIAN
+3336.22%
vs the sector median at left
Nutriband Inc.
Market Cap
$80.32M
Debt to Assets Ratio
3.09%
TTM Avg
2.99%
3Y Avg
2.90%
5Y Avg
2.49%
Market Cap
$80.19M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$79.11M
Debt to Assets Ratio
0.16%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$78.35M
Debt to Assets Ratio
0.49%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$82.82M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$77.80M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$77.15M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nutriband Inc. (NTRB) | $80.32M | 3.09% | 2.99% | 2.90% | 2.49% |
| Citius Oncology, Inc. (CTOR)vs › | $80.19M | 0.09% | N/A | N/A | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.11M | 0.16% | N/A | N/A | N/A |
| Pulmonx Corporation (LUNG)vs › | $78.35M | 0.49% | N/A | N/A | N/A |
| MediciNova, Inc. (MNOV)vs › | $82.45M | 0.00% | N/A | N/A | N/A |
| LENSAR Inc (LNSR)vs › | $82.59M | 0.03% | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $82.82M | 0.02% | N/A | N/A | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.80M | 0.06% | N/A | N/A | N/A |
| Sera Prognostics, Inc. (SERA)vs › | $77.15M | 0.03% | N/A | N/A | N/A |
| ProMIS Neurosciences, Inc. (PMN)vs › | $83.53M | 0.00% | N/A | N/A | N/A |
Debt/Assets
3.1%
Debt/Equity
0.04
Current Ratio
4.21
Interest Coverage
-369.1x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-07-31 | 3.09% |
| 2026-04-30 | 3.38% |
| 2026-01-31 | 3.25% |
| 2025-10-31 | 2.57% |
| 2025-07-31 | 2.66% |
| 2025-04-30 | 4.59% |
| 2025-01-31 | 2.49% |
| 2024-10-31 | 1.60% |
| 2024-07-31 | 1.57% |
| 2024-04-30 | 3.48% |
| 2024-01-31 | 3.21% |
| 2023-10-31 | 26.84% |
| 2023-07-31 | 22.97% |
| 2023-04-30 | 2.57% |
| 2023-01-31 | 1.96% |
| 2022-10-31 | 1.87% |
| 2022-07-31 | 1.92% |
| 2022-04-30 | 1.99% |
| 2022-01-31 | 1.06% |
| 2021-10-31 | 1.46% |
| 2021-07-31 | 17.78% |
| 2021-04-30 | 16.86% |
| 2021-01-31 | 18.01% |
| 2020-10-31 | 18.81% |
| 2020-07-31 | 6.34% |
| 2020-04-30 | 0.63% |
| 2020-01-31 | 14.63% |
| 2019-10-31 | 8.40% |
| 2019-07-31 | 4.66% |
| 2019-04-30 | 1.79% |
| 2019-01-31 | 1.42% |
| 2018-10-31 | 1.53% |
| 2018-07-31 | 1.30% |
| 2018-04-30 | 74.58% |
| 2018-01-31 | 18.83% |
| 2017-10-31 | 1.09% |
| 2017-07-31 | 0.46% |
| 2017-04-30 | 125.35% |
| 2017-01-31 | 27.75% |
| 2016-10-31 | 162.39% |
| 2016-07-31 | 51.75% |
| 2016-04-30 | 18.13% |
| 2016-01-31 | 3212.42% |
